# SLC12A2

## Overview
The SLC12A2 gene encodes the Na-K-Cl cotransporter 1 (NKCC1), a critical transmembrane protein involved in the transport of sodium (Na+), potassium (K+), and chloride (Cl-) ions across cell membranes. This protein plays a vital role in maintaining cellular ion balance and volume, influencing various physiological processes such as fluid secretion, neuronal excitability, and blood pressure regulation (Yang2020Structure; Markadieu2013Physiology). NKCC1 is characterized by its 12 transmembrane domains and is regulated through phosphorylation by kinases such as SPAK and OSR1, which modulate its activity (Koumangoye2020NKCC1:). Mutations in the SLC12A2 gene are linked to several clinical conditions, including Kilquist syndrome and NKCC1 deficiency syndrome, which manifest in symptoms ranging from hearing loss to neurodevelopmental disorders (Macnamara2019Kilquist; Stödberg2020SLC12A2). The gene's significance in ion transport underscores its importance in both normal physiology and disease states.

## Structure
The SLC12A2 gene encodes the NKCC1 protein, a Na+-K+-2Cl- cotransporter involved in ion transport across cell membranes. The protein is composed of 1212 amino acids and features 12 transmembrane domains, which form the core structure of the protein (Markadieu2013Physiology; Hebert2004Molecular). The transmembrane domains are organized in a 5 + 5 symmetry, followed by two additional α-helical segments, contributing to the protein's function in ion transport (Markadieu2013Physiology).

The NKCC1 protein has cytoplasmic N- and C-terminal domains. The N-terminal domain is highly flexible and contains conserved threonine residues that are phosphorylated by the WNK-SPAK/OSR1 kinase pathway, which is crucial for activating the cotransporter (Koumangoye2020NKCC1:). The C-terminal domain includes a string of three successive glutamate residues, which are important for maintaining the protein's structural integrity (Adadey2021Further).

NKCC1 forms functional dimers, with a domain-swap dimer architecture where the transmembrane domain of one protomer interacts with the C-terminal domain of the other, although the functional significance of this dimerization is not fully understood (Hebert2004Molecular; Koumangoye2020NKCC1:). Splice variants of NKCC1 have been identified, including one lacking exon 21, which affects the protein's regulatory mechanisms (Randall1997Partial).

## Function
The SLC12A2 gene encodes the Na-K-Cl cotransporter NKCC1, which is crucial for maintaining ion balance and cell volume in healthy human cells. NKCC1 facilitates the electroneutral transport of Na+, K+, and Cl- ions across cell membranes, utilizing the ion gradients established by the Na+/K+-ATPase. This transport occurs in a 1Na+, 1K+, and 2Cl- ratio, functioning as a secondary active transport mechanism (Markadieu2013Physiology).

In epithelial cells, NKCC1 is located on the basolateral membrane, where it plays a key role in fluid secretion, such as in the salivary glands and intestines, and is essential for maintaining proper peristalsis in the gastrointestinal tract (Markadieu2013Physiology). In neurons, NKCC1 helps maintain elevated intracellular Cl- levels, influencing the polarity of GABA responses and contributing to neuronal excitability (Yang2020Structure).

NKCC1 is also involved in regulating blood pressure and vascular tone, as its inhibition can lead to hypotension (Markadieu2013Physiology). The protein's activity is regulated by phosphorylation events and dimerization dynamics, which are crucial for its function in chloride entry into cells (Monette2012Regulatory).

## Clinical Significance
Mutations in the SLC12A2 gene, which encodes the Na-K-Cl cotransporter 1 (NKCC1), are associated with several clinical conditions. Kilquist syndrome is a novel syndromic hearing loss disorder caused by a homozygous deletion of the SLC12A2 gene. This condition is characterized by sensorineural deafness, absence of saliva, tears, and sweat, mucus plugging, respiratory problems, and severe gastrointestinal issues (Macnamara2019Kilquist). 

SLC12A2 mutations also lead to NKCC1 deficiency syndrome, which presents with neurological symptoms and secretory impairments. Patients exhibit severe neurodevelopmental disorders, hearing impairment, and a lack of tear fluid, saliva, and sweat (Stödberg2020SLC12A2). Variants affecting exon 21 of SLC12A2 are linked to hereditary hearing loss, as they disrupt the inclusion of this exon in the transcript, leading to a truncated isoform that affects cochlear function (Mutai2020Variants).

In neurodevelopment, SLC12A2 variants have been implicated in disorders characterized by developmental delay, intellectual disability, and sensorineural hearing loss. These mutations reduce NKCC1 function, impacting neurogenesis and cochleovestibular development (McNeill2020SLC12A2). The gene's role in ion transport and cellular ion balance is crucial for normal physiological processes, and its dysfunction can lead to multisystem diseases.

## Interactions
The SLC12A2 gene encodes the NKCC1 protein, which is involved in various protein interactions crucial for its function as a Na+, K+, 2Cl- cotransporter. NKCC1 interacts with protein phosphatase-1 (PP1) and stress-related protein kinases, which are important for its regulation. The NH2-terminal domain of NKCC1 contains motifs that bind these proteins, indicating a role in modulating NKCC1 activity through dephosphorylation (Hebert2004Molecular). 

NKCC1 also interacts with Ste20 kinases SPAK and OSR1 through a core RFXV motif located in its N-terminal tail. This interaction is essential for the phosphorylation and activation of the cotransporter. The presence of two such motifs in NKCC1 suggests a complex regulatory mechanism involving these kinases (Markadieu2013Physiology). 

In the cochlea, SLC12A2 signals colocalize with ATP1B1 in strial marginal cells, suggesting a potential interaction or co-localization with this protein, which may be significant for ion transport and homeostasis in the inner ear (Mutai2020Variants). Despite these known interactions, direct protein-protein interaction studies for SLC12A2 are limited, and further research is needed to fully elucidate its interaction network (Adadey2022Cellbased).


## References


[1. (Adadey2022Cellbased) Samuel Mawuli Adadey, Edmond Wonkam-Tingang, Leonardo Alves de Souza Rios, Elvis Twumasi Aboagye, Kevin Esoh, Noluthando Manyisa, Carmen De Kock, Gordon A. Awandare, Shaheen Mowla, and Ambroise Wonkam. Cell-based analysis of clic5a and slc12a2 variants associated with hearing impairment in two african families. Frontiers in Genetics, August 2022. URL: http://dx.doi.org/10.3389/fgene.2022.924904, doi:10.3389/fgene.2022.924904. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2022.924904)

[2. (Macnamara2019Kilquist) Ellen F. Macnamara, Alanna E. Koehler, Precilla D’Souza, Tyra Estwick, Paul Lee, Gilbert Vezina, Harper Fauni, Stephen R. Braddock, Erin Torti, James Matthew Holt, Prashant Sharma, May Christine V. Malicdan, and Cynthia J. Tifft. Kilquist syndrome: a novel syndromic hearing loss disorder caused by homozygous deletion ofslc12a2: macnamara<scp>et al.</scp>. Human Mutation, 40(5):532–538, March 2019. URL: http://dx.doi.org/10.1002/humu.23722, doi:10.1002/humu.23722. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.23722)

[3. (Monette2012Regulatory) Michelle Y. Monette and Biff Forbush. Regulatory activation is accompanied by movement in the c terminus of the na-k-cl cotransporter (nkcc1). Journal of Biological Chemistry, 287(3):2210–2220, January 2012. URL: http://dx.doi.org/10.1074/jbc.m111.309211, doi:10.1074/jbc.m111.309211. This article has 40 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m111.309211)

[4. (McNeill2020SLC12A2) Alisdair McNeill, Emanuela Iovino, Luke Mansard, Christel Vache, David Baux, Emma Bedoukian, Helen Cox, John Dean, David Goudie, Ajith Kumar, Ruth Newbury-Ecob, Chiara Fallerini, Alessandra Renieri, Diego Lopergolo, Francesca Mari, Catherine Blanchet, Marjolaine Willems, Anne-Francoise Roux, Tommaso Pippucci, and Eric Delpire. Slc12a2 variants cause a neurodevelopmental disorder or cochleovestibular defect. Brain, 143(8):2380–2387, July 2020. URL: http://dx.doi.org/10.1093/brain/awaa176, doi:10.1093/brain/awaa176. This article has 35 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/brain/awaa176)

[5. (Stödberg2020SLC12A2) Tommy Stödberg, Måns Magnusson, Nicole Lesko, Anna Wredenberg, Daniel Martin Munoz, Henrik Stranneheim, and Anna Wedell. Slc12a2 mutations cause nkcc1 deficiency with encephalopathy and impaired secretory epithelia. Neurology Genetics, August 2020. URL: http://dx.doi.org/10.1212/NXG.0000000000000478, doi:10.1212/nxg.0000000000000478. This article has 25 citations.](https://doi.org/10.1212/NXG.0000000000000478)

[6. (Yang2020Structure) Xiaoyong Yang, Qinzhe Wang, and Erhu Cao. Structure of the human cation–chloride cotransporter nkcc1 determined by single-particle electron cryo-microscopy. Nature Communications, February 2020. URL: http://dx.doi.org/10.1038/s41467-020-14790-3, doi:10.1038/s41467-020-14790-3. This article has 42 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-020-14790-3)

[7. (Markadieu2013Physiology) Nicolas Markadieu and Eric Delpire. Physiology and pathophysiology of slc12a1/2 transporters. Pflügers Archiv - European Journal of Physiology, 466(1):91–105, October 2013. URL: http://dx.doi.org/10.1007/s00424-013-1370-5, doi:10.1007/s00424-013-1370-5. This article has 107 citations.](https://doi.org/10.1007/s00424-013-1370-5)

[8. (Randall1997Partial) Jeffrey Randall, Tina Thorne, and Eric Delpire. Partial cloning and characterization of slc12a2: the gene encoding the secretory na+-k+-2cl−cotransporter. American Journal of Physiology-Cell Physiology, 273(4):C1267–C1277, October 1997. URL: http://dx.doi.org/10.1152/ajpcell.1997.273.4.C1267, doi:10.1152/ajpcell.1997.273.4.c1267. This article has 97 citations.](https://doi.org/10.1152/ajpcell.1997.273.4.C1267)

[9. (Mutai2020Variants) Hideki Mutai, Koichiro Wasano, Yukihide Momozawa, Yoichiro Kamatani, Fuyuki Miya, Sawako Masuda, Noriko Morimoto, Kiyomitsu Nara, Satoe Takahashi, Tatsuhiko Tsunoda, Kazuaki Homma, Michiaki Kubo, and Tatsuo Matsunaga. Variants encoding a restricted carboxy-terminal domain of slc12a2 cause hereditary hearing loss in humans. PLOS Genetics, 16(4):e1008643, April 2020. URL: http://dx.doi.org/10.1371/journal.pgen.1008643, doi:10.1371/journal.pgen.1008643. This article has 39 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1371/journal.pgen.1008643)

[10. (Hebert2004Molecular) Steven C. Hebert, David B. Mount, and Gerardo Gamba. Molecular physiology of cation-coupled cl? cotransport: the slc12 family. Pfl�gers Archiv European Journal of Physiology, 447(5):580–593, February 2004. URL: http://dx.doi.org/10.1007/s00424-003-1066-3, doi:10.1007/s00424-003-1066-3. This article has 221 citations.](https://doi.org/10.1007/s00424-003-1066-3)

[11. (Adadey2021Further) Samuel M. Adadey, Isabelle Schrauwen, Elvis Twumasi Aboagye, Thashi Bharadwaj, Kevin K. Esoh, Sulman Basit, Anushree Acharya, Liz M. Nouel-Saied, Khurram Liaqat, Edmond Wonkam-Tingang, Shaheen Mowla, Gordon A. Awandare, Wasim Ahmad, Suzanne M. Leal, and Ambroise Wonkam. Further confirmation of the association of slc12a2 with non-syndromic autosomal-dominant hearing impairment. Journal of Human Genetics, 66(12):1169–1175, July 2021. URL: http://dx.doi.org/10.1038/s10038-021-00954-6, doi:10.1038/s10038-021-00954-6. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s10038-021-00954-6)

[12. (Koumangoye2020NKCC1:) Rainelli Koumangoye, Lisa Bastarache, and Eric Delpire. Nkcc1: newly found as a human disease-causing ion transporter. Function, November 2020. URL: http://dx.doi.org/10.1093/function/zqaa028, doi:10.1093/function/zqaa028. This article has 34 citations.](https://doi.org/10.1093/function/zqaa028)